Julia Thornton Snider, PhD
Senior Director, Policy & Economics
Dr. Snider is an expert in innovative approaches to product valuation and advanced econometric analyses using healthcare data. At PHE, Dr. Snider has led numerous studies in oncology, diabetes, and nutrition, including a study that was awarded third place out of 573 accepted abstracts at the 2013 annual congress of the European Society for Clinical Nutrition and Metabolism (ESPEN). An avid public speaker, Dr. Snider has presented her research in numerous settings, including giving presentations on HIV/AIDS and robotic surgery at Health Affairs issue briefings in Washington, DC. Dr. Snider joined PHE from the UCLA Anderson Forecast, where she contributed to the highly respected quarterly economic forecast by providing expertise on the healthcare sector, among other things. Dr. Snider has previously worked as a researcher at the Federal Reserve Bank of Minneapolis and at the World Bank branch offices in Buenos Aires and Moscow. She has been featured in the popular press, including the Los Angeles Times, MSNBC, and the Daily Finance, on a variety of topics.
PhD, Economics, University of Minnesota
BA, Economics, Stanford University
ASSOCIATED CASE STUDIES
Option value of cancer treatments
- Chandra A, et al. Robot-assisted surgery for kidney cancer increased access to a procedure that can reduce mortality and renal failure. Health Aff (Millwood). 2015.
- Philipson TJ, et al. Impact of nutritional supplementation on hospital outcomes. Am J Manag Care. 2013.
- Philipson TJ, et al. The social value of childhood vaccination in the United States. Am J Manag Care. 2017.
- Snider JT, et al. Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid. Health Aff (Millwood). 2014.
- Snider JT, et al. The option value of innovative treatments for non-small cell lung cancer and renal cell carcinoma. Am J Manag Care. 2017.